Therapeutic Advances in Chronic Disease
eISSN:
20406231 | ISSN:
20406223 | Current volume: 14 | Current issue: 1
Frequency: Yearly
Journal Highlights
- Launched in 2010
- Gold open access journal – all articles are made freely available online immediately upon publication
- Rigorous peer review
- Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE) and Scopus
- Reaches a broad, multidisciplinary audience
- Over 600 000 full-text article views annually
Therapeutic Advances in Chronic Disease (TACD) is a peer-reviewed open access journal which focuses on the highest quality research, reviews and scholarly comment on pioneering efforts and innovative studies across all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers, providing a forum in print and online for publishing the highest quality articles in this area. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
Diversity, Equity and Inclusion Statement
Therapeutic Advances in Chronic Disease (TACD) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the chronic disease community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/tacd.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Unsolicited manuscripts submitted to Therapeutic Advances in Chronic Disease are currently subject to an Article Processing Charge (APC) of 2950 USD payable upon acceptance. These articles will be published under a Creative Commons licence and will be made openly available.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Please direct any queries to TAChronicDisease@sagepub.com.
Therapeutic Advances in Chronic Disease delivers the highest quality peer-reviewed, open access, original research articles, reviews, and scholarly comment on pioneering efforts across all areas of chronic disease. The journal has a strong clinical focus and is aimed at an international audience of clinicians, researchers, and allied health practitioners in chronic disease, providing an online forum for rapid dissemination of recent research and perspectives in this area. The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.
Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, health-economic and pharma-economic reviews are also welcomed. The appropriate EQUATORnetwork reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of the first patient enrolment.
Managing Editor
| Hemali Bedi | SAGE Publications Ltd, London, UK |
| Gayatri More | SAGE Publishing, New Delhi, India |
Associate Editor - Cardiology
| Stephen Hoole | Royal Papworth Hospital, Cambridge, UK |
Associate Editor - Dermatology
| Lluís Puig | Universitat Autònoma de Barcelona, Barcelona, Spain |
Associate Editor - Endocrinology
| Thozhukat Sathyapalan | University of Hull, Kingston upon Hull, UK |
Associate Editor - Gastroenterology
| Ian Beales | Norfolk and Norwich University Hospital, Norfolk, UK |
Associate Editor - Nephrology
| Ashish Verma | Boston University Chobanian & Avedisian School of Medicine, Boston, USA |
Associate Editor - Neurology
| Jan Kassubek | University of Ulm, Ulm, Germany |
Associate Editor – Rheumatology
| Pankaj Bansal | Mayo Clinic College of Medicine, Wisconsin, USA |
Associate Editor - Respiratory
| Lucia Spicuzza | University of Catania, Catania, Italy |
Associate Editor – Hepatology
| Liang Qiao | The University of Sydney, Westmead, Australia |
Biostatistical Editors
| Ram Bajpai | School of Medicine, Keele University, UK |
Editorial Board
| Kathryn Abel | University of Manchester, Manchester, UK |
| Bo Abrahamsen | Copenhagen University Hospital Gentofte, Hellerup, Denmark |
| Frazer H Anderson | Southampton University, UK |
| Riitta Antikainen | Oulu City Hospital, Oulu, Finland |
| Jianfeng Bao | Hangzhou Xixi Hospital, Zhejiang University School Of Medicine, Hangzhou, China |
| Mainak Bardhan | Miami Cancer Institute, Florida, FL, USA |
| Srikanth Bellary | Aston University, Birmingham, UK |
| Michael Berk | University of Melbourne, Australia |
| Michael Blackburn | University of Texas, USA |
| Xavier Calvet | Hospital de Sabadell, Spain |
| Gemma Casadesus | Case Western Reserve University, USA |
| Rudolph Castellani | University of Maryland, MD, USA |
| Mario Cazzola | University of Rome "Tor Vergata", Rome, Italy |
| Pascal Chanez | University of the Mediterranian, Marseille, France |
| Martin Connolly | University of Auckland, New Zealand |
| Leonardo M. Fabbri | University of Modena and Reggio Emilia, Italy |
| Serge Ferrari | Hopitaux Universitaires de Geneve, Switzerland |
| Stephen Gallacher | Southern General Hospital, Glasgow, Scotland |
| Javier P. Gisbert | La Princesa University Hospital, Madrid, Spain |
| Neil Gittoes | Queen Elizabeth Hospital, Birmingham, UK |
| Mugdha Gokhale | Pfizer, Collegeville and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA |
| Nicola Hanania | Baylor College of Medicine, Houston, TX, USA |
| Zhen Hong, MD, PhD | West China Hospital, Sichuan University, Sichuan, China |
| Elaine Hylek | Boston Medical Center, Boston, MA, USA |
| Chunmeng Jiang | Dalian Medical University 2nd Hospital, Dalian, Liaoning, China |
| Peter Joyce | Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand |
| Matthew C. Kiernan | Brain and Mind Centre, University of Sydney, Australia |
| Sarah Kingsbury | Chapel Allerton Hospital, Leeds, UK |
| Constantine E. Kosmas | National and Kapodistrian University of Athens, University General Hospital “ATTIKON”, Athens, Greece |
| Anastasios Koulaouzidis | University of Southern Denmark, Denmark |
| Hyoung-gon Lee | Case Western Reserve University, Cleveland, OH, USA |
| Yiling Li | Department of Gastroenterology and Hepatology, The First Hospital of China Medical University, Shenyang, Liaoning, China |
| Ricardo Maccioni | University of Chile Medical School, Chile |
| Mario Malerba | University of Eastern Piedmont, Vercelli, Italy |
| Marco Manfredini | University of Modena and Reggio Emilia, Modena, Italy |
| Arduino Mangoni | Flinders Medical Centre and Flinders University, Bedford Park, Australia |
| Tahir Masud | Nottingham University, Nottingham, UK |
| Eugene McCloskey | University of Sheffield, Sheffield, UK |
| Terry McCormack | Whitby Medical Practice, UK |
| Andrew McIntosh | University of Edinborgh, UK |
| Francesco Menzella | AULSS2 Marca Trevigiana, Italy |
| Paula Moreira | University of Coimbra, Portugal |
| Jaymin Morjaria | Harefield Hospital, UK |
| Bjorn Moum | Faculty Div. Aker University Hospital, Norway |
| Yuemin Nan | Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Hebei, China |
| Anthony O'Connor | Adelaide and Meath Hospital, Ireland |
| Pierluigi Paggiaro | University of Pisa, Pisa, Italy |
| Sanjeev Patel | St Helier University Hospital, Carshalton, UK |
| George Perry | The University of Texas at San Antonio, USA |
| Ruth Peters | Imperial College, London, UK |
| Riccardo Polosa | Az. Ospedaliero-Universitaria Vittorio Emanuele, Catania, Italy |
| James Potash | Mood Disorders Centre, Baltimore, USA |
| Beatrice Ragnoli | S.Andrea Hospital- University of Eastern Piedmont, Vercelli, Italy |
| Huiying Rao | Hepatology Institute, Peking University People’s Hospital, Beijing, China |
| Marianne Uggen Rasmussen | The Parker Institute, Copenhagen University Hospital, Denmark |
| Craig Ritchie | University of Edinburgh, UK |
| Francesco Roselli | Ulm University and DZNE-Ulm, Ulm, Germany |
| Thomas Schulze | Georg-August-University Göttingen, Germany |
| Monish Sheth | Baylor College of Medicine, Temple, TX, USA |
| Shun Shinohama | Sapporo Medical University, Japan |
| Massimo Tabaton | University of Genoa, Genoa, Italy |
| Professor Rajesh Tampi, MD, MS | Yale School of Medicine, New Haven, CT, USA & Creighton University School of Medicine, Omaha, NE, USA |
| Ahmed Tawheed | Helwan University, Cairo, Egypt |
| Irina Turchin | Brunswick Dermatology Center, Fredericton, Canada |
| Hua Wang | Institute for Liver Disease, First Affiliated Hospital of Anhui Medical University, Anhui, China |
| Lakshmi Yatham | University of British Columbia, Canada |
| Junmin Zhang | Lanzhou University, Lanzhou, China |
| Ming-Hua Zheng | MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China |
| Xiongwei Zhu | Case Western Reserve University, USA |
Editorial Review Board
| Brent Gawey, MD, MSc | Mayo Clinic (Rochester, MN), USA |
| Sneha S. Pillai, PhD | Marshall University, USA |
| Luyu Xie | University of Texas, USA |
Manuscript submission guidelines can be accessed on Sage Journals.